An Open-label Randomised Pragmatic Policy Trial Of Nicotine Products For Short-term Cessation Assistance Or Long-term Substitution In Smokers.
Funder
National Health and Medical Research Council
Funding Amount
$1,053,910.00
Summary
Many smokers who try to quit fail in their attempt. Medicinal nicotine is currently only used as a short-term quit aid. This trial will test if offering smokers the option of using these products as long-term substitutes for cigarettes will help more smokers to successfully quit. We will also determine if offering smokers low toxicity smokeless tobacco and electronic nicotine devices in addition to medicinal nicotine products further increases the number of smokers who quit successfully.
The Future Of Tobacco Control: Exploring The Feasibility, Acceptability And Cost-effectiveness Of New Policy Directions
Funder
National Health and Medical Research Council
Funding Amount
$495,752.00
Summary
We will examine the practical feasibility, ethical and public acceptability, and likely cost effectiveness of a number of different ways of reducing tobacco smoking and the harm caused by smoking in Australia. These policy options will include: (1) more restrictive policies towards tobacco products (such as prohibiting tobacco smoking and creating a government monopoly on the manufacture and supply of tobacco); (2) encouraging smokers to switch from smoking cigarettes to less harmful ways of usi ....We will examine the practical feasibility, ethical and public acceptability, and likely cost effectiveness of a number of different ways of reducing tobacco smoking and the harm caused by smoking in Australia. These policy options will include: (1) more restrictive policies towards tobacco products (such as prohibiting tobacco smoking and creating a government monopoly on the manufacture and supply of tobacco); (2) encouraging smokers to switch from smoking cigarettes to less harmful ways of using nicotine, such as using nicotine patches or gum ; (3) using new biotechnologies to improve smokers chances of quitting (e.g. genetic screening of smokers to select the most effective way of helping them to stop smoking and vaccinating ex-smokers against the effects of nicotine); and (4) new biotechnologies that may prevent nonsmokers from beginning to smoke (e.g. vaccinating nonsmokers against the effects of nicotine) or reduce the chances of their developing tobacco-related diseases (e.g. screening the population for genes that predict an increased susceptibility to nicotine dependence and tobacco-related diseases). The project will provide important information that will assist government in formulating policies to reduce the rate of cigarette smoking in the Australian population below current levels.Read moreRead less
Evaluating The Effectiveness Of Future Tobacco Control Strategies
Funder
National Health and Medical Research Council
Funding Amount
$368,112.00
Summary
This research will evaluate promising new strategies to reduce the harm caused by tobacco, the leading preventable cause of premature death in Australia. This includes evaluation of general population-based strategies, such as public smoking bans, and interventions to help smokers quit smoking, such as new cessation aids and long-term maintenance on pharmaceutical nicotine or low-nitrosamine smokeless tobacco.